ZWJ Investment Counsel’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.8M | Sell |
565,752
-37,879
| -6% | -$4.07M | 2.26% | 12 |
|
|
2025
Q1 | $60.9M | Sell |
603,631
-13,673
| -2% | -$1.38M | 2.48% | 9 |
|
|
2024
Q4 | $55.1M | Buy |
617,304
+1,761
| +0.3% | +$157K | 2.28% | 13 |
|
|
2024
Q3 | $51.6M | Sell |
615,543
-2,755
| -0.4% | -$231K | 2.11% | 13 |
|
|
2024
Q2 | $47.6M | Buy |
618,298
+12,162
| +2% | +$937K | 2.09% | 14 |
|
|
2024
Q1 | $41.5M | Sell |
606,136
-20,464
| -3% | -$1.4M | 1.89% | 23 |
|
|
2023
Q4 | $36.2M | Sell |
626,600
-7,739
| -1% | -$447K | 1.86% | 24 |
|
|
2023
Q3 | $33.5M | Sell |
634,339
-1,380
| -0.2% | -$72.9K | 1.86% | 22 |
|
|
2023
Q2 | $34.4M | Sell |
635,719
-7,710
| -1% | -$417K | 1.8% | 24 |
|
|
2023
Q1 | $32.2M | Sell |
643,429
-10,417
| -2% | -$521K | 1.78% | 26 |
|
|
2022
Q4 | $30.3M | Buy |
653,846
+3,788
| +0.6% | +$175K | 1.71% | 27 |
|
|
2022
Q3 | $25.2M | Buy |
650,058
+22,600
| +4% | +$875K | 1.58% | 31 |
|
|
2022
Q2 | $23.4M | Buy |
627,458
+24,463
| +4% | +$912K | 1.37% | 33 |
|
|
2022
Q1 | $26.7M | Sell |
602,995
-6,397
| -1% | -$283K | 1.41% | 35 |
|
|
2021
Q4 | $25.9M | Buy |
609,392
+14,200
| +2% | +$603K | 1.32% | 35 |
|
|
2021
Q3 | $25.8M | Buy |
595,192
+6,913
| +1% | +$300K | 1.46% | 32 |
|
|
2021
Q2 | $25.2M | Buy |
588,279
+15,232
| +3% | +$651K | 1.45% | 33 |
|
|
2021
Q1 | $22.1M | Buy |
573,047
+14,923
| +3% | +$577K | 1.36% | 37 |
|
|
2020
Q4 | $20.1M | Buy |
558,124
+331,189
| +146% | +$11.9M | 1.36% | 29 |
|
|
2020
Q3 | $8.67M | Buy |
226,935
+127,055
| +127% | +$4.85M | 0.7% | 45 |
|
|
2020
Q2 | $3.51M | Buy |
99,880
+29,980
| +43% | +$1.05M | 0.3% | 55 |
|
|
2020
Q1 | $2.28M | Buy |
+69,900
| New | +$2.28M | 0.2% | 70 |
|